By www.reliableresearchiq.com
Global And United States B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report & Forecast 2024-2031 Story
104
$ 4350
B-Cell Maturation Antigen (BCMA) Targeted Therapies Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Transposagen Biopharmaceuticals Sutro Biopharma Malin Corporation Eureka Therapeutics firstVentury Equity Five Prime Therapeutics Credit Suisse Securities Dana-Farber Cancer Institute Deerfield Partners Onyx Pharmaceuticals Juno Therapeutics